Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 11/20 | 0.56 |
| ▸ | LPL | P06858 | 10/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.48 |
| ▸ | F11 | P03951 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10269020 | 0.94 | LPL (0.56) | LIPGLPLHTTCA1CA2 | |
| SCHEMBL17439342 | 0.84 | LIPG (0.51) | LIPGLPLHTTCYP1A2FFAR1 | |
| SCHEMBL9933163 | 0.83 | FFAR1 (0.48) | LIPGLPLCA1CA2CA12 | |
| SCHEMBL28388836 | 0.82 | LPL (0.50) | LIPGLPLHTTCA1CA2 | |
| SCHEMBL15549532 | 0.80 | LTA4H (0.42) | LIPGLPLHTTALDH1A1DGAT1 | |
| SCHEMBL15550766 | 0.80 | DGAT1 (0.53) | LIPGLPLALDH1A1DGAT1 | |
| SCHEMBL31240616 | 0.80 | DGAT1 (0.53) | LIPGLPLALDH1A1DGAT1 | |
| SCHEMBL17800073 | 0.79 | DGAT1 (0.49) | LIPGLPLDGAT1 | |
| SCHEMBL9986019 | 0.78 | CA1 (0.61) | LIPGLPLCA1CA2CA12 | |
| SCHEMBL1129188 | 0.78 | LPL (0.65) | LIPGLPLCA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116492300-A | Magnetic micro-robot with ROS response and shape self-adaptability, and preparation method and application thereof | 华南理工大学 | 2023-07-28 | — | — | CN | disclosed |
| CN-111777699-A | Preparation method of boric acid functional group resin | 中国科学院青岛生物能源与过程研究所 | 2020-10-16 | — | — | CN | disclosed |
| US-8299290-B2 | Boron containing functionalizing agent | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2012-10-30 | — | — | US | disclosed |
| US-20120029234-A1 | BORON CONTAINING FUNCTIONALIZING AGENT | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2012-02-02 | — | — | US | disclosed |
| US-8063152-B2 | Boron containing functionalizing agent | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2011-11-22 | — | — | US | disclosed |
| WO-2010010184-A1 | [1, 2, 4] TRIAZOLO [1, 5-A] PYRIDINES AS JAK INHIBITORS | GALAPAGOS NV (BE) | 2010-01-28 | — | — | WO | disclosed |
| US-20090229729-A1 | BORON CONTAINING FUNCTIONALIZING AGENT | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090229729-A1 | BORON CONTAINING FUNCTIONALIZING AGENT | BOLA2; BOLA2B, RBBP4, BRPF1 | LIPG 2409/4885LPL 3041/4885HTT 1753/4885 |
| US-20120029234-A1 | BORON CONTAINING FUNCTIONALIZING AGENT | BOLA2; BOLA2B, RBBP4, BRPF1 | LIPG 2409/4885LPL 3041/4885HTT 1753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.